This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Check out our community’s Pharma predictions: Dave Latshaw, CEO at BioPhy The competitive dynamics of the pharmaceutical industry will undergo substantial reorganization in 2025. The role of AI-native pharmaceutical companies will expand significantly in 2025, building on the momentum of billions in investment from previous years.
Tom Lawry may be best-known as a leading voice on AI in health care; after all, hes written two very well-selling books on the topic, speaks all over the world on the subject, and in his most recent company-based gig helped lead Microsofts efforts in AI in health care and lifesciences.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .
CitiusTech , a leader in healthcare technology and consulting services, today announced that it has acquired Wilco Source , one of the world’s leading providers of Salesforce consulting and implementation services for healthcare and lifesciences companies. patient and provider portals) (Salesforce Communities).
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including lifesciences, provider, imaging, health plan, employer, and government health and human services. Watson has had some success in healthcare, but it has also faced a number of challenges.
Molly and I then segued into how the health system incumbent players — hospitals, plans, clinicians, and lifescience companies — can (and should be) part of the telehealth ecosystem and solutions to deliver care, everywhere. Thanks to Microsoft for its leadership in enabling better healthcare, everywhere.
Kelly Nguyen is a multi-award-winning, seasoned executive with a proven track record in the pharmaceutical and healthcare industry. DrKumo, with Dr. Nguyen’s leadership, continues to achieve notable awards since its foundation. BUENA PARK, CALIFORNIA, UNITED STATES OF AMERICA, May 6, 2022— DrKumo Inc., Hunter International Recruiting.
Chris McSpiritt, Head of LifeSciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care.
Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & The Committee to Restore Nymox Shareholder Value, Inc.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and lifesciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
Studies A survey from ixlayer and Ipsos found 81% of patients with chronic conditions said pharmaceutical companies should provide resources to help them get the care and medicines they need. The company is under fire, with a class action lawsuit filed against Oracle in Florida and an FBI investigation underway.
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital LifeScience. Solas puts patients first.
The following is a guest article by Sheetal Chawla, Head of LifeSciences and Head of Northeast Region at Capgemini Americas , and Stephen Obana, Vice President of LifeSciences at Capgemini Americas The healthcare sector has long been globally recognized as one of the leading carbon-intensive industries, accounting for 4.5%
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the lifesciences. Forbion invests in lifesciences companies that are active in the (bio) pharmaceutical space.
Additionally, Authenticx’s customer base doubled over the last year, with its client portfolio now including five of the top 10 leading global pharmaceutical companies. “By Unsolicited customer feedback is a valuable resource for healthcare and lifescience organizations.
Building great AI models in healthcare and lifesciences requires lots of data that is diverse, well-labeled, and spans across different patient types. Previously, she was in product development, business development and marketing for radiology, genomics, pharmaceutical, chemistry, and bioinformatics companies using AI.
About Ferdinand Hamada Ferdinand Hamada is a Managing Director for the cybersecurity practice at MorganFranklin and leads the Healthcare, Pharmaceutical, & LifeSciences (HPLS) industry sector. Additionally, Ferdinand held various positions within Information Technology at Cardinal Health and Merck.
This first-of-its-kind event is being hosted by the Department of Health – Abu Dhabi and aims to be a landmark platform for international collaboration on the future of healthcare and lifesciences. This could include discussions on healthcare disparities and strategies for achieving better health outcomes for all.
This deal would give Apple a major presence in the pharmaceutical and consumer healthcare markets. This deal would give Microsoft a major presence in the pharmaceutical distribution market. McKesson is one of the leading pharmaceutical distributors in the world, with a wide range of products and services.
The following is a guest article by Abhishek Khandelwal, Vice President, LifeSciences at Capgemini Engineering The convergence of digital technology and healthcare has been underway for quite some time, but as we inch closer to 2024, the pace of change that this sector is experiencing is unprecedented.
Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations.
A pharmaceutical company could use Med-PaLM to develop new drugs or to improve the efficiency of their drug discovery process. HealthTech Thought Leadership from Nelson Advisors - Industry Insights & Analysis for Founders, Owners & Investors. Buy Side, Sell Side, Growth and Strategy mandates - Email lloyd@nelsonadvisors.co.uk
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. The company raised $10m in 2022.
Teva Pharmaceuticals is partnering with Healthsnap and Rimidi to increase patient access to the Digihaler system. Twilio launched a version of Segment , its Customer Data Platform, for healthcare and lifesciences. RxSpark and Capital Rx have partnered to increase access to affordable medications at the point of purchase.
I’d love to see more provider organizations and lifescience organizations coming together to further patient care and do that through research and the potentials for new medicines.
Pharmaceutical and lab distributor Cardinal Health is collaborating with Signify Health to offer in-home clinical and medication management services. Real-world evidence provider Atropos Health has teamed with OMNY Health to improve data sharing among patients, providers, and lifesciences companies.
One area we see automation already making a positive shift is pharmaceutical manufacturing. Companies like Cellares are evolving pharmaceutical manufacturing and applying automation to unite science and commercial production capabilities.
We had a small team that worked closely with pharmaceutical companies and generated revenue from these relationships. I wasn’t very involved with this team, but due to my ownership of many of the clinical decision support initiatives, I started getting invited to meetings we had with pharmaceutical companies.
New research has found that healthcare organizations around the world have big plans for digital transformation but often stumble when it comes to implementing this process.
Tallying up the years between her working in physician practice management and the pharmaceutical sector, as well as time spent in health advocacy, “I’ve been 25 years in health care,” Stacy calculated. Parexel is a Clinical Research Organization that crafts and conducts clinical trials on behalf of lifescience companies.
“BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. We’re thrilled to partner with BPS to alleviate critical pain points for its customers and to help them provide life-changing therapies to patients around the world.”
In the past decade, I’ve been spending a lot of time considering SDoH through a variety of lenses across the health/care ecosystem, including care providers like hospitals, health insurance companies, pharma and lifescience, retail health care front doors, and non-profits and foundations.
Earlier in his career, Mr. Kamkolkar served in enterprise data science, digital & AI leadership roles at Sanofi and Novartis. Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. Jane Rhodes, Ph.D., Jane Rhodes, Ph.D.,
to approve Medicare’s negotiation of drug prices with pharmaceutical companies]. “Without a trusted leadership source to look to,” Edelman explains, “people don’t know where or who to get reliable information [from].” Hospitals’ fall from 70% to 63% between 2018 and 2019.
today unveiled its groundbreaking platform, designed to significantly accelerate speed to market in the lifesciences industry. At a time when rapid commercialization is more critical than ever, Axonal.AI’s cutting-edge technology promises to transform how pharmaceutical companies bring products to market. “Axonal.AI
This investment brings Revisto’s total funding to $6 million, positioning the company to transform the pharmaceutical and lifescience industry’s often tedious and financially burdensome approach to marketing compliance.
How will we know if the lifesciences sector is advancing in 2025? This is the question asked at the start of the report, a Research Brief: 2025 Indicators of Progress for the LifeSciences Sector, from the IQVIA Institute for Human Data Science (IQVIA). We start with the state of trust held by U.S.
voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. This morning we don’t have a transcript of the speech ahead of the event, but one topic remains high on U.S. Few issues unite U.S.
When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 We needed leadership and a plan,” Dr. Berwick commented on the situation. a pill to $750 a pill. “The U.S.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content